Pfizer Leads An Unusual Year For The Scrip 100
Executive Summary
Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.
Outlook
2023
Annual Industry Ranking And Forecast
Topics
- Originals
- Outlook 2023
- Subjects
- Sales & Earnings
- Companies
- Commercial
- Market Intelligence
- Growth
- Generic Drugs
- Coronavirus COVID-19
- Industries
- BioPharmaceutical
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IV146771
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
IV146771
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.